{"id":608903,"date":"2024-06-07T17:42:20","date_gmt":"2024-06-07T21:42:20","guid":{"rendered":"https:\/\/platohealth.ai\/at-long-last-geron-wins-fda-approval-of-first-drug\/"},"modified":"2024-06-08T12:56:28","modified_gmt":"2024-06-08T16:56:28","slug":"at-long-last-geron-wins-fda-approval-of-first-drug","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/at-long-last-geron-wins-fda-approval-of-first-drug\/","title":{"rendered":"At long last, Geron wins FDA approval of first drug","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
ARTICLE | Regulation<\/p>\n
\n By Paul Bonanos, Director of Biopharma Intelligence<\/span>\n<\/p>\n June 7, 2024 9:42 PM UTC<\/p>\n<\/div>\n<\/div>\n<\/div>\n Geron had to wait 34 years to gain its first FDA approval, but at least the agency didn\u2019t make the company wait until its June 16 PDUFA date.<\/p>\n Late Thursday, Geron Corp.<\/a> (NASDAQ:GERN) said FDA approved Rytelo imetelstat, its DNA oligonucleotide inhibitor of telomerase, to treat lower-risk myelodysplastic syndromes in patients with transfusion-dependent anemia. The approval covers patients who are relapsed or refractory to, or ineligible for, erythropoiesis-stimulating agents…<\/p>\n ARTICLE | Regulation The 34-year-old company will bring to market Rytelo imetelstat for some patients with myelodysplastic syndromes By Paul Bonanos, Director of Biopharma Intelligence June 7, 2024 9:42 PM UTC Geron had to wait 34 years to gain its first FDA approval, but at least the agency didn\u2019t make the company wait until its […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":608907,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[50],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/608903"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=608903"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/608903\/revisions"}],"predecessor-version":[{"id":608906,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/608903\/revisions\/608906"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/608907"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=608903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=608903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=608903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/span><\/div>\n
\n